Compound ID | 1855
Class: Aminoglycoside
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Protein synthesis inhibitor. Binds to the bacterial 30S ribosomal subunit |
| Target Pathogen: | Active against Gram-positive and Gram-negative bacteria |
| Description: | Semisynthetic, derived from streptomycin. Used in veterinary medicine |
| Year first mentioned: | 1949 |
| Highest development stage: | Approved |
| Development status: | Withdrawn |
| Reason dropped: | Risk of ototoxicity/ irreversible hearing loss |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/439369 |
| Guide to Pharmacology: | dihydrostreptomycin |
| Citation: | https://www.nejm.org/doi/full/10.1056/NEJM194905052401810 |